Intercept Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ICPT *?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	7,812	0.0187%
Individual Insiders	1,116,975	2.68%
VC/PE Firms	4,000,000	9.6%
General Public	7,620,986	18.3%
Institutions	28,941,311	69.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 40.3%.

Top Shareholders

Top 25 shareholders own 63.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.6%	Genextra S.p.A.	4,000,000	Mex$819.8m	0%	no data
9.44%	The Vanguard Group, Inc.	3,935,919	Mex$806.6m	8.19%	no data
7.34%	BlackRock, Inc.	3,058,944	Mex$626.9m	-0.84%	no data
7.33%	State Street Global Advisors, Inc.	3,054,510	Mex$626.0m	-3.82%	no data
2.52%	Renaissance Technologies LLC	1,050,200	Mex$215.2m	48.3%	0.02%
2.22%	Jacobs Levy Equity Management Inc	923,369	Mex$189.2m	0.03%	0.07%
1.96%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	815,448	Mex$167.1m	2.2%	no data
1.76%	Rockefeller & Co. LLC	735,488	Mex$150.7m	30.1%	0.04%
1.67%	Pictet Asset Management Limited	694,637	Mex$142.4m	182%	0.01%
1.65%	Macquarie Investment Management Business Trust	686,267	Mex$140.6m	2.12%	0.01%
1.64%	Millennium Management LLC	682,406	Mex$139.9m	-30.1%	0.01%
1.54%	Samsara BioCapital LLC	640,688	Mex$131.3m	0%	1.52%
1.52%	Goldman Sachs Group, Investment Banking and Securities Investments	631,736	Mex$129.5m	67.2%	no data
1.48%	Mark Pruzanski	618,894	Mex$126.8m	0%	no data
1.44%	Geode Capital Management, LLC	599,338	Mex$122.8m	2.45%	no data
1.37%	D. E. Shaw & Co., L.P.	570,025	Mex$116.8m	175%	0.01%
1.2%	Eventide Asset Management, LLC	501,033	Mex$102.7m	-37.4%	0.1%
1.19%	Two Sigma Advisers, LP	497,900	Mex$102.0m	-8.71%	0.02%
1.06%	Jupiter Fund Management Plc	440,753	Mex$90.3m	4.54%	0.02%
1.05%	Adage Capital Management, L.P.	438,437	Mex$89.9m	0%	0.01%
0.98%	Acadian Asset Management LLC	409,593	Mex$83.9m	4.53%	0.02%
0.95%	Citigroup Inc.,Banking and Securities Investments	397,465	Mex$81.5m	5.53%	0.01%
0.8%	Charles Schwab Investment Management, Inc.	334,169	Mex$68.5m	20.3%	no data
0.75%	Bank of America Corporation, Asset Management Arm	314,377	Mex$64.4m	-34.6%	no data
0.65%	Northern Trust Global Investments	272,192	Mex$55.8m	1.19%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/06/12 01:24
End of Day Share Price	2023/03/15 00:00
Earnings	2023/03/31
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Intercept Pharmaceuticals, Inc. is covered by 28 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
James Birchenough	BMO Capital Markets Equity Research
Geoffrey Meacham	BofA Global Research
Mayank Mamtani	B. Riley Securities, Inc.